8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study
Show simple item record
Files in this item
| Title: |
8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study |
| Author(s): |
Benford, Marnita L.; VanCleave, Tiva T.; Lavender, Nicole A.; Kittles, Rick A.; Kidd, LaCreis R.
|
| Subject(s): |
chromosome 8Q24
prostate cancer
|
| Abstract: |
Background: Human chromosome 8q24 has been implicated in prostate tumorigenesis.
Methods: Consequently, we evaluated seven 8q24 sequence variants relative to prostate cancer (PCA) in a case-control study involving men of African descent. Genetic alterations were detected in germ-line DNA from 195 incident PCA cases and 531 controls using TaqMan polymerase chain reaction (PCR).
Results: Inheritance of the 8q24 rs16901979 T allele corresponded to a 2.5-fold increase in the risk of developing PCA for our test group. These findings were validated using multifactor dimensionality reduction (MDR) and permutation testing (p = 0.038). The remaining 8q24 targets were not significantly related to PCA outcomes.
Conclusions: Although compelling evidence suggests that the 8q24 rs16901979 locus may serve as an effective PCA predictor, our findings require additional evaluation in larger studies. |
| Issue Date: |
2010-06-28 |
| Publisher: |
BioMed Central |
| Citation Info: |
Benford, M. L., VanCleave, T. T., Lavender, N. A., Kittles, R. A., & Kidd, L. R. 2010. 8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study. BMC Cancer, 10. DOI: 10.1186/1471-2407-10-334 |
| Type: |
Article |
| Description: |
The original source for this publication is at BioMed Central; DOI: 10.1186/1471-2407-10-334. © 2010 Benford et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. |
| URI: |
http://hdl.handle.net/10027/7621
|
| ISSN: |
1471-2407 |
| Sponsor: |
This study was supported in part by the NIH R03 CA128028, the James Graham Brown Cancer Center, and the Bucks for Brains "Our Highest Potential" in Cancer Research Endowment. |
| Date Available in INDIGO: |
2011-05-12 |
Items in INDIGO are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
Show simple item record